Sector valuations DaShenLin Pharmaceutical Group Co., Ltd.
Stocks
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.29 CNY | +0.87% |
|
+2.32% | -7.55% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 12.5x | 2.34x | 0.6x | 0.5x | 4x | 6.6x | 5.53% | 2.73B | |
| 15.73x | 1.64x | 1.81x | 0.7x | 7.29x | 9.19x | 2.37% | 5.85B | |
| 12.19x | 1.83x | 0.75x | 0.77x | 5.54x | 7.25x | 3.52% | 3.44B | |
| 15.87x | 7.18x | 2.43x | 0.96x | 7.2x | 10x | 4.07% | 3.32B | |
| 14.51x | 4.38x | 13.83x | 1.23x | 7.47x | 14.49x | 5.7% | 3.24B | |
| 40.98x | - | 1.3x | - | - | - | - | 2.66B | |
| 23.31x | 4.08x | 1.01x | 0.67x | 8.56x | 14.02x | 1.76% | 1.73B | |
| -90.72x | 2.98x | 1.52x | 0.47x | 17.66x | 106.75x | 0.01% | 1.58B | |
| 45.87x | 5.04x | 1.09x | 1.34x | 15.44x | 29.57x | - | 1.03B | |
| 11.81x | 2.38x | -4.21x | 0.87x | 7.07x | 13.34x | 5.61% | 985M | |
| 10.89x | 0.78x | 0.1x | 0.25x | 2.43x | 5.01x | 4.66% | 860M | |
| 27.97x | 7.53x | 1.15x | 1x | 13.72x | 21.75x | 1.31% | 824M | |
| 12.87x | 1.74x | 1.06x | 0.63x | 7.76x | 12.53x | 0.4% | 636M | |
| -5.73x | 1.4x | 0.11x | 0.53x | -34.33x | -9.7x | -.--% | 550M | |
| 7x | 0.74x | 0.28x | 0.24x | 3.76x | 4.52x | 1.78% | 506M | |
| Average | 10.34x | 3.15x | 1.52x | 0.73x | 5.25x | 17.52x | 2.82% | 2B | |
| Weighted average by Cap. | 12.48x | 3.25x | 2.48x | 0.78x | 6.88x | 16.15x | 3.35% |
Select your edition
All financial news and data tailored to specific country editions
